Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Amortizatization of Intangibles (2019 - 2025)

Historic Amortizatization of Intangibles for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $465000.0.

  • Pulmonx's Amortizatization of Intangibles rose 5500.0% to $465000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 3577.27%. This contributed to the annual value of $1.8 million for FY2024, which is 3134.77% down from last year.
  • As of Q3 2025, Pulmonx's Amortizatization of Intangibles stood at $465000.0, which was up 5500.0% from $255000.0 recorded in Q2 2025.
  • In the past 5 years, Pulmonx's Amortizatization of Intangibles ranged from a high of $701000.0 in Q1 2024 and a low of $255000.0 during Q2 2025
  • Its 5-year average for Amortizatization of Intangibles is $550947.4, with a median of $612000.0 in 2022.
  • Per our database at Business Quant, Pulmonx's Amortizatization of Intangibles surged by 16854.46% in 2021 and then plummeted by 5542.35% in 2024.
  • Pulmonx's Amortizatization of Intangibles (Quarter) stood at $594000.0 in 2021, then rose by 7.58% to $639000.0 in 2022, then rose by 7.82% to $689000.0 in 2023, then plummeted by 51.67% to $333000.0 in 2024, then skyrocketed by 39.64% to $465000.0 in 2025.
  • Its last three reported values are $465000.0 in Q3 2025, $255000.0 for Q2 2025, and $360000.0 during Q1 2025.